Skip to content

Acupuncture-like Transcutaneous Electrical Nerve Stimulation on Bowel Symptom and Quality of Life in Patients With Irritable Bowel Syndrome

National Taipei University of Nursing and Health Sciences

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05042661
Enrollment
30
Registered
2021-09-13
Start date
2021-02-01
Completion date
2023-02-13
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture-like Transcutaneous Electrical Nerve Stimulation, Irritable Bowel Syndrome

Keywords

irritable bowel syndrome, acupuncture-like transcutaneous electrical nervestimulation, quality of life

Brief summary

To discuss the effects of improving the irritable bowel syndrome patients' quality of life and defecation after implementing acupuncture-like Transcutaneous Electrical nerve stimulation.

Detailed description

This experiment will use a clinical design that will collect cases in a local teaching hospital. The way of convenience sampling will gather from the irritable bowel syndrome patients. After a questionnaire, randomly to make invention and control groups. Invention and control groups are 4 weeks and 3 weeks respectively. Each time will be for 20 minutes acupuncture-like transcutaneous electrical nerve stimulation treatment. The Control group will still have normal nursing. There will be 72 patients in two groups. The measured timing will be in the second, fourth, and eighth weeks after the prediction and invention.

Interventions

DEVICEacupuncture-like transcutaneous electrical nerve stimulation

The intervention group performed Al-TENS therapy 3 times a week for at least 20 minutes each time for 4 consecutive weeks. The second, fourth, and eighth week after the intervention.

Sponsors

National Taipei University of Nursing and Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Those who are at least 20 years old (inclusive) and are willing to sign a written informed consent after explaining the purpose of the research. 2. A patient with irritable bowel syndrome diagnosed by a doctor for at least 6 months (inclusive). 3. Communicate in Mandarin or Hokkien.

Exclusion criteria

1. Those who cannot take care of themselves in daily life. 2. Those who have had severe abdominal and colorectal surgery. 3. Those who have been diagnosed with inflammatory bowel disease or colorectal cancer. 4. Those with a history of mental illness, such as schizophrenia and obsessive- compulsive disorder. 5. Women who are pregnant, breastfeeding, and less than 12 months after delivery. 6. Other serious diseases, such as acute myocardial infarction, endocrine disease, decompensated cirrhosis, stroke, and end-stage renal disease, etc.

Design outcomes

Primary

MeasureTime frameDescription
WHOQOL-BREF,Taiwan versionpretestThere are a total of 28 questions on this scale, of which 26 are common questions around the world, and the other 2 are local questions. This questionnaire is a positive question and a five-point scoring system. The higher the score, the better the quality of life.
irritable bowel syndrome Severity ScorepretestThere are a total of 5 questions on this scale. This questionnaire is a positive question type. The score of each item can be from 0 to 100. Therefore, the overall severity of IBS ranges from 0 to 500. The severity of symptoms can be divided into mild; moderate; severe, the higher the score, the more severe the IBS symptoms
Irritable Bowel Syndrome Quality of LifepretestThis questionnaire has a total of 34 questions, all of which are positive questions, and are scored with five points, divided into 1 point = completely no, 2 points = a little bit, 3 points = medium, 4 points = equivalent, 5 points = extreme. The score range is 34\ 170 points, the higher the score, the worse the quality of life
Bristol Stool Form ScalepretestThe first and second types of stool show that the patient has constipation, the first type is more serious than the second type; the normal stool types are the third and fourth types, and the fifth to seventh types are suspected Diarrhea (Lewis, & Heaton, 1997), the above description indicates that the lower the score, the more severe the constipation symptoms, and vice versa, the more severe the diarrhea symptoms

Other

MeasureTime frameDescription
Part 1: Basic personal information:Basic and disease information list 5pretestWork
Part 1: Basic personal information:Basic and disease information list 6pretestreligion
Part 1: Basic personal information:Basic and disease information list 7pretestfamily history
Part 1: Basic personal information:Basic and disease information list 8pretestHistory of chronic disease
Basic and disease information list 9pretestsmokes
Part 1: Basic personal information:Basic and disease information list 10pretestdrink wine
Part 1: Basic personal information:Basic and disease information list 1pretestgender
Part 1: Basic personal information:Basic and disease information list 12pretestSleep status
Part 1: Basic personal information:Basic and disease information list 13pretestSpecial eating habits
Part 1: Basic personal information:Basic and disease information list 14pretestExercise habits
Part 2: Symptoms of Irritable Bowel Syndrome:Basic and disease information list 1pretestIrritable bowel disease onset time
Part 2: Symptoms of Irritable Bowel Syndrome:Basic and disease information list 2pretestBowel movement
Part 2: Symptoms of Irritable Bowel Syndrome:Basic and disease information list 3pretesttreatment
Part 1: Basic personal information:Basic and disease information list 11pretestBetel nut
Part 1: Basic personal information:Basic and disease information list 2pretestDate of birth
Part 1: Basic personal information:Basic and disease information list 3pretestmarital status
Part 1: Basic personal information:Basic and disease information list 4pretesteducation level

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026